Related Experiment Video
Updated: May 21, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling
Thomas A Trikalinos1, Shalini Kulasingam, William F Lawrence
1Center for Evidence-based Medicine, and Department of Health Services Policy and Practice, Brown University, Providence, RI 02912, USA. thomas_trikalinos@brown.edu
Most medical test reviews focus on accuracy, not patient outcomes. Modeling can link test performance to patient outcomes, improving medical test usefulness assessment.
Area of Science:
- Medical Decision Making
- Health Services Research
- Biostatistics
Background:
- Systematic reviews often prioritize test accuracy over patient outcomes.
- The relationship between test results and patient outcomes is complex and not guaranteed.
- Test performance alone is insufficient for evaluating medical test utility.
Purpose of the Study:
- To propose modeling as a framework for linking test performance to patient outcomes.
- To facilitate the interpretation of summary test performance measures.
- To connect medical testing and patient outcomes.
Main Methods:
- Utilizing decision or economic analysis modeling.
- Developing a simple algorithm for systematic reviewers.
- Illustrating the approach with a practical example.
Main Results:
- Modeling provides a natural framework to bridge test performance and clinical outcomes.
- The proposed algorithm aids reviewers in considering the impact of testing on outcomes.
- The example demonstrates the practical application of linking test performance to patient benefits.
Conclusions:
- Modeling is crucial for a comprehensive assessment of medical test usefulness.
- Connecting test performance data with patient outcomes enhances clinical decision-making.
- Systematic reviews should consider incorporating modeling to evaluate the true impact of medical tests.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Decision Making: P-value Method
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can have a...
Decision Making: Traditional Method
First, a specific claim about the population parameter is decided based on the research question and is stated in a simple form. Further, an opposing statement to this claim is also stated. These statements can act as null and alternative hypotheses, out of which a null hypothesis would be a...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
